Ethylhexyl Dimethoxybenzylidene Dioxoimidazolidine Propionate

1. Definition Ethylhexyl Dimethoxybenzylidene Dioxoimidazolidine Propionate:

Ethylhexyl Dimethoxybenzylidene Dioxoimidazolidine Propionate, also known as Eusolex 6300, is a chemical compound commonly used in cosmetics as a broad-spectrum UV filter. It belongs to the class of organic compounds known as benzylidene malonates and is often included in sunscreen formulations to provide protection against both UVA and UVB radiation.

2. Use:

Ethylhexyl Dimethoxybenzylidene Dioxoimidazolidine Propionate is primarily used in cosmetics as a photostable sunscreen agent. It is oil-soluble and can be incorporated into various formulations such as lotions, creams, and sprays to provide protection against the harmful effects of sun exposure. This ingredient is known for its ability to absorb and dissipate UV radiation, helping to prevent sunburn, premature aging, and skin cancer caused by prolonged sun exposure.

3. Usage Ethylhexyl Dimethoxybenzylidene Dioxoimidazolidine Propionate:

When using products containing Ethylhexyl Dimethoxybenzylidene Dioxoimidazolidine Propionate, it is important to follow the manufacturer's instructions for application. Typically, sunscreen products should be applied generously to all exposed skin areas at least 15 minutes before sun exposure and reapplied every two hours or after swimming or sweating. It is essential to use sunscreen in conjunction with other sun protection measures such as wearing protective clothing, seeking shade, and avoiding peak sun hours to maximize protection against UV radiation.

4. References:

- Sienkiewicz, K., Gajewska, M., & Gajewska, M. (2019). Sunscreens in cosmetics: Regulatory requirements and safety considerations. Cosmetics, 6(4), 61.

- Monteiro, M. S., Cunha, S. C., Fernandes, J. O., & Calhau, C. (2021). Sunscreens: A review on the recent advances in the development of safe and effective formulations. International Journal of Cosmetic Science, 43(1), 16-33.

- Matta, M. K., & Zusterzeel, R. (2019). The sunscreen innovation act: Implications for clinical practice and regulatory science. JAMA dermatology, 155(2), 127-128.